Takemasa Hayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takemasa Hayashi has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Toshiyuki Baba
Digestive Disease Center Showa Medical University Northern Yokohama Hospital Kanagawa Japan
7 shared publications- Katsuro Ichimasa
Digestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Japan
5 shared publications Kunihiko Wakamura
Digestive Disease Center Showa Medical University Northern Yokohama Hospital Kanagawa Japan
5 shared publicationsShin‐Ei Kudo
Digestive Disease Center Showa Medical University Northern Yokohama Hospital Kanagawa Japan
5 shared publicationsTetsuo Nemoto
Department of Diagnostic Pathology Showa Medical University Northern Yokohama Hospital Kanagawa Japan
5 shared publicationsYuta Kouyama
Digestive Disease Center Showa Medical University Northern Yokohama Hospital Kanagawa Japan
5 shared publications
Latest Publications
- Open Access
White Light, Magnifying Endoscopy, Endocytoscopy, and Artificial Intelligence in Diagnosis of Early Colorectal Cancer: A Comparative Study
Objectives: Early detection of colorectal cancer is critical for improving prognosis. However, assessing invasion depth—distinguishing between superficial cancer (T1a) and deep submucosal invasive cancer (T1b)—remains challenging. Recently, artificial intelligence (AI)‐assisted computer‐aided diagnosis (CADx) systems have been introduced to complement conventional endoscopy. This study aims to compare the diagnostic accuracy of endoscopists in predicting deep submucosal invasion in early colorectal cancer under four modalities: white‐light imaging (WLI), magnifying endoscopy (including narrow‐band imaging magnification and pit pattern), endocytoscopy (EC), and CADx support. Methods: We conducted a single‐center retrospective study using stored endoscopic images between April 2021 and December 2022. Each lesion was evaluated using white light imaging, magnifying endoscopy, EC, and CADx analysis with the EndoBRAIN‐Plus system. Trainee and expert endoscopists assessed the images sequentially, recording their estimations of invasion depth (T1a vs. T1b) and confidence levels. Sensitivity, specificity, and accuracy were calculated against the pathological reference. We compared performances stratified by confidence level and endoscopist experience. Results: During the study period, 66 lesions were eligible. Of them, 27% (18 lesions) were T1b cancers. Diagnostic accuracy improved progressively from white light imaging (82.7% [95% confidence interval {95%CI}: 81.2–86.9]) to EC (85.6% [95%CI: 82.7–88.2]). The highest specificity and accuracy were achieved when AI‐assisted diagnosis was incorporated (accuracy: 88.9% [95%CI: 86.3–91.2], specificity: 93.1% [95%CI: 90.6–95.2]). The proportion of high‐confidence readings rose from 40.2% to 75.5%. This was most pronounced in the trainee group. Conclusions: Integrating advanced endoscopic imaging with CADx significantly improved accuracy in assessing invasion depth. This approach may guide treatment decisions in early‐stage colorectal cancer.
Open AccessWhite Light, Magnifying Endoscopy, Endocytoscopy, and Artificial Intelligence in Diagnosis of Early Colorectal Cancer: A Comparative Study
Objectives: Early detection of colorectal cancer is critical for improving prognosis. However, assessing invasion depth—distinguishing between superficial cancer (T1a) and deep submucosal invasive cancer (T1b)—remains challenging. Recently, artificial intelligence (AI)‐assisted computer‐aided diagnosis (CADx) systems have been introduced to complement conventional endoscopy. This study aims to compare the diagnostic accuracy of endoscopists in predicting deep submucosal invasion in early colorectal cancer under four modalities: white‐light imaging (WLI), magnifying endoscopy (including narrow‐band imaging magnification and pit pattern), endocytoscopy (EC), and CADx support. Methods: We conducted a single‐center retrospective study using stored endoscopic images between April 2021 and December 2022. Each lesion was evaluated using white light imaging, magnifying endoscopy, EC, and CADx analysis with the EndoBRAIN‐Plus system. Trainee and expert endoscopists assessed the images sequentially, recording their estimations of invasion depth (T1a vs. T1b) and confidence levels. Sensitivity, specificity, and accuracy were calculated against the pathological reference. We compared performances stratified by confidence level and endoscopist experience. Results: During the study period, 66 lesions were eligible. Of them, 27% (18 lesions) were T1b cancers. Diagnostic accuracy improved progressively from white light imaging (82.7% [95% confidence interval {95%CI}: 81.2–86.9]) to EC (85.6% [95%CI: 82.7–88.2]). The highest specificity and accuracy were achieved when AI‐assisted diagnosis was incorporated (accuracy: 88.9% [95%CI: 86.3–91.2], specificity: 93.1% [95%CI: 90.6–95.2]). The proportion of high‐confidence readings rose from 40.2% to 75.5%. This was most pronounced in the trainee group. Conclusions: Integrating advanced endoscopic imaging with CADx significantly improved accuracy in assessing invasion depth. This approach may guide treatment decisions in early‐stage colorectal cancer.
- Open Access
Usefulness of the Bridge Formation Method for Colorectal Endoscopic Submucosal Dissection: A Propensity Score‐Matched Study
Aims: Colorectal endoscopic submucosal dissection (ESD) has become a standard treatment for superficial colorectal neoplasms worldwide. However, challenges remain in achieving dissection at the precise layer. In this study, we evaluated the effectiveness of a novel ESD technique involving natural traction, referred to as the bridge formation method (BFM).Methods and Results: The two main features of the BFM are creating a large mucosal flap and leaving normal mucosa on both sides of the lesion until the bridge is made at the end of the procedure. This retrospective study included consecutive patients with 2647 colorectal lesions resected by ESD from September 2003 to December 2023. We divided them into the BFM group and the non‐BFM group and conducted propensity score matching.After propensity score matching, 1648 cases were enrolled (824 cases in each group). The en bloc resection rate was significantly higher in the BFM than non‐BFM group (99.6% vs. 96.7%, p < 0.01). The R0 resection rate and the average dissection speed (㎟/min) were significantly higher in the BFM than non‐BFM group (98.8% vs. 96.4%, p < 0.01, and 18.9 vs. 18.0, p = 0.03). The occurrence rates of perforation and delayed bleeding showed no significant difference between the non‐BFM and BFM groups (2.8% vs. 3.6%, p = 0.40, and 1.1% vs. 1.0%, p = 1.00).Conclusions: The BFM is a suitable method for colorectal ESD as it enables rapid dissection and improves both en bloc resection and R0 resection rates.
Open AccessUsefulness of the Bridge Formation Method for Colorectal Endoscopic Submucosal Dissection: A Propensity Score‐Matched Study
Aims: Colorectal endoscopic submucosal dissection (ESD) has become a standard treatment for superficial colorectal neoplasms worldwide. However, challenges remain in achieving dissection at the precise layer. In this study, we evaluated the effectiveness of a novel ESD technique involving natural traction, referred to as the bridge formation method (BFM).Methods and Results: The two main features of the BFM are creating a large mucosal flap and leaving normal mucosa on both sides of the lesion until the bridge is made at the end of the procedure. This retrospective study included consecutive patients with 2647 colorectal lesions resected by ESD from September 2003 to December 2023. We divided them into the BFM group and the non‐BFM group and conducted propensity score matching.After propensity score matching, 1648 cases were enrolled (824 cases in each group). The en bloc resection rate was significantly higher in the BFM than non‐BFM group (99.6% vs. 96.7%, p < 0.01). The R0 resection rate and the average dissection speed (㎟/min) were significantly higher in the BFM than non‐BFM group (98.8% vs. 96.4%, p < 0.01, and 18.9 vs. 18.0, p = 0.03). The occurrence rates of perforation and delayed bleeding showed no significant difference between the non‐BFM and BFM groups (2.8% vs. 3.6%, p = 0.40, and 1.1% vs. 1.0%, p = 1.00).Conclusions: The BFM is a suitable method for colorectal ESD as it enables rapid dissection and improves both en bloc resection and R0 resection rates.
- Open Access
Lymph node metastasis risk factors in T2 colorectal cancer
Objectives: This study evaluates risk factors for lymph node metastasis (LNM) in T2 colorectal cancer to refine patient selection for endoscopic resection.Methods: We reviewed records from consecutive patients who had undergone curative surgical resection of T2 colorectal cancer at our institution in Japan between April 2001 and December 2021. Data on conventional clinicopathologic variables were retrieved from the pathology reports at the time of surgery. The clinicopathological features included patient age, sex, tumor diameter, morphology, tumor location, lymphatic invasion, vascular invasion, tumor differentiation, carcinoembryonic antigen and carbohydrate antigen 19‐9 levels, number of lymph node dissections, presence of adenoma component, and LNM.Results: Among the patients (338 men, 320 women), 170 (25.8%) exhibited LNM. Multivariate logistic regression identified three independent risk factors for LNM: lymphatic invasion (odds ratio [OR], 32.6; 95% confidence interval [CI], 17.3–61.4; p < 0.0001), female sex (OR, 1.70; 95% CI, 1.10–2.62; p = 0.02), and elevated carcinoembryonic antigen levels (OR, 2.56; 95% CI, 1.10–5.96; p = 0.03).Conclusions: Lymphatic invasion, female sex, and high carcinoembryonic antigen levels significantly increase the risk of LNM in T2 colorectal cancer.
Open AccessLymph node metastasis risk factors in T2 colorectal cancer
Objectives: This study evaluates risk factors for lymph node metastasis (LNM) in T2 colorectal cancer to refine patient selection for endoscopic resection.Methods: We reviewed records from consecutive patients who had undergone curative surgical resection of T2 colorectal cancer at our institution in Japan between April 2001 and December 2021. Data on conventional clinicopathologic variables were retrieved from the pathology reports at the time of surgery. The clinicopathological features included patient age, sex, tumor diameter, morphology, tumor location, lymphatic invasion, vascular invasion, tumor differentiation, carcinoembryonic antigen and carbohydrate antigen 19‐9 levels, number of lymph node dissections, presence of adenoma component, and LNM.Results: Among the patients (338 men, 320 women), 170 (25.8%) exhibited LNM. Multivariate logistic regression identified three independent risk factors for LNM: lymphatic invasion (odds ratio [OR], 32.6; 95% confidence interval [CI], 17.3–61.4; p < 0.0001), female sex (OR, 1.70; 95% CI, 1.10–2.62; p = 0.02), and elevated carcinoembryonic antigen levels (OR, 2.56; 95% CI, 1.10–5.96; p = 0.03).Conclusions: Lymphatic invasion, female sex, and high carcinoembryonic antigen levels significantly increase the risk of LNM in T2 colorectal cancer.
- Open Access
Differentiation grade as a risk factor for lymph node metastasis in T1 colorectal cancer
Objectives: Japanese guidelines include high‐grade (poorly differentiated) tumors as a risk factor for lymph node metastasis (LNM) in T1 colorectal cancer (CRC). However, whether the grading is based on the least or most predominant component when the lesion consists of two or more levels of differentiation varies among institutions. This study aimed to investigate which method is optimal for assessing the risk of LNM in T1 CRC.Methods: We retrospectively evaluated 971 consecutive patients with T1 CRC who underwent initial or additional surgical resection from 2001 to 2021 at our institution. Tumor grading was divided into low‐grade (well‐ to moderately differentiated) and high‐grade based on the least or predominant differentiation analyses. We investigated the correlations between LNM and these two grading analyses.Results: LNM was present in 9.8% of patients. High‐grade tumors, as determined by least differentiation analysis, accounted for 17.0%, compared to 0.8% identified by predominant differentiation analysis. A significant association with LNM was noted for the least differentiation method (p < 0.05), while no such association was found for predominant differentiation (p = 0.18). In multivariate logistic regression, grading based on least differentiation was an independent predictor of LNM (p = 0.04, odds ratio 1.68, 95% confidence interval 1.00–2.83). Sensitivity and specificity for detecting LNM were 27.4% and 84.1% for least differentiation, and 2.1% and 99.3% for predominant differentiation, respectively.Conclusions: Tumor grading via least differentiation analysis proved to be a more reliable measure for assessing LNM risk in T1 CRC compared to grading by predominant differentiation.
Open AccessDifferentiation grade as a risk factor for lymph node metastasis in T1 colorectal cancer
Objectives: Japanese guidelines include high‐grade (poorly differentiated) tumors as a risk factor for lymph node metastasis (LNM) in T1 colorectal cancer (CRC). However, whether the grading is based on the least or most predominant component when the lesion consists of two or more levels of differentiation varies among institutions. This study aimed to investigate which method is optimal for assessing the risk of LNM in T1 CRC.Methods: We retrospectively evaluated 971 consecutive patients with T1 CRC who underwent initial or additional surgical resection from 2001 to 2021 at our institution. Tumor grading was divided into low‐grade (well‐ to moderately differentiated) and high‐grade based on the least or predominant differentiation analyses. We investigated the correlations between LNM and these two grading analyses.Results: LNM was present in 9.8% of patients. High‐grade tumors, as determined by least differentiation analysis, accounted for 17.0%, compared to 0.8% identified by predominant differentiation analysis. A significant association with LNM was noted for the least differentiation method (p < 0.05), while no such association was found for predominant differentiation (p = 0.18). In multivariate logistic regression, grading based on least differentiation was an independent predictor of LNM (p = 0.04, odds ratio 1.68, 95% confidence interval 1.00–2.83). Sensitivity and specificity for detecting LNM were 27.4% and 84.1% for least differentiation, and 2.1% and 99.3% for predominant differentiation, respectively.Conclusions: Tumor grading via least differentiation analysis proved to be a more reliable measure for assessing LNM risk in T1 CRC compared to grading by predominant differentiation.
- Open Access
Endoscopic submucosal dissection for colorectal neoplasms: Risk factors for local recurrence and long‐term surveillance
Objectives: Endoscopic submucosal dissection (ESD) is an effective procedure for the en bloc resection of colorectal neoplasms. However, risk factors for local recurrence after ESD have not been identified. This study aimed to evaluate such risk factors after ESD for colorectal neoplasms.Methods: This retrospective study included 1344 patients with 1539 consecutive colorectal lesions who underwent ESD between September 2003 and December 2019. We investigated various factors associated with local recurrence in these patients. The main outcomes were the incidence of local recurrence and its relationship with clinicopathological factors during long‐term surveillance.Results: The en bloc resection rate was 98.6%, the R0 resection rate was 97.2%, and the histologically complete resection rate was 92.7%. Local recurrence was observed in 7/1344 (0.5%) patients and the median follow‐up period was 72 months (range 4–195 months). The incidence of local recurrence was significantly higher in lesions ≥40 mm in diameter (hazard ratio [HR] 15.68 [1.88–130.5]; p = 0.011), piecemeal resection (HR 48.42 [10.7–218.7]; p < 0.001), non‐R0 resection (HR 41.05 [9.025–186.7]; p < 0.001), histologically incomplete resection (HR 16.23 [3.627–72.63]; pp = 0.037).Conclusions: Five risk factors for local recurrence after ESD were identified. Patients with such factors should undergo careful surveillance colonoscopy.
Open AccessEndoscopic submucosal dissection for colorectal neoplasms: Risk factors for local recurrence and long‐term surveillance
Objectives: Endoscopic submucosal dissection (ESD) is an effective procedure for the en bloc resection of colorectal neoplasms. However, risk factors for local recurrence after ESD have not been identified. This study aimed to evaluate such risk factors after ESD for colorectal neoplasms.Methods: This retrospective study included 1344 patients with 1539 consecutive colorectal lesions who underwent ESD between September 2003 and December 2019. We investigated various factors associated with local recurrence in these patients. The main outcomes were the incidence of local recurrence and its relationship with clinicopathological factors during long‐term surveillance.Results: The en bloc resection rate was 98.6%, the R0 resection rate was 97.2%, and the histologically complete resection rate was 92.7%. Local recurrence was observed in 7/1344 (0.5%) patients and the median follow‐up period was 72 months (range 4–195 months). The incidence of local recurrence was significantly higher in lesions ≥40 mm in diameter (hazard ratio [HR] 15.68 [1.88–130.5]; p = 0.011), piecemeal resection (HR 48.42 [10.7–218.7]; p < 0.001), non‐R0 resection (HR 41.05 [9.025–186.7]; p < 0.001), histologically incomplete resection (HR 16.23 [3.627–72.63]; pp = 0.037).Conclusions: Five risk factors for local recurrence after ESD were identified. Patients with such factors should undergo careful surveillance colonoscopy.
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB533-AB534
CLINICAL AND PATHOLOGICAL FEATURES OF DEPRESSED-TYPE COLORECTAL NEOPLASM
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB533-AB534
CLINICAL AND PATHOLOGICAL FEATURES OF DEPRESSED-TYPE COLORECTAL NEOPLASM
- Open Access
- 9 November 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 35 (1) , E11-E12
Bridge formation method in colorectal endoscopic submucosal dissection
Watch a video of this article.
- 9 November 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 35 (1) , E11-E12
Open AccessBridge formation method in colorectal endoscopic submucosal dissection
Watch a video of this article.
- Open Access
- 28 September 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (6) , 7264-7270
Clinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion
With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).
- 28 September 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (6) , 7264-7270
Open AccessClinicopathological features of T1 colorectal carcinomas with skip lymphovascular invasion
With recent advances in endoscopic treatment, many T1 colorectal carcinomas (CRCs) are resected endoscopically with a negative margin. However, some lesions exhibit skip lymphovascular invasion (SLVI), which is defined as the discontinuous foci of the tumor cells within the colon wall. The aim of the present study was to reveal the clinicopathological features of T1 CRCs with SLVI and validate the Japanese guidelines regarding SLVI. A total of 741 patients with T1 CRCs that were resected surgically between April 2001 and October 2016 in our hospital were divided into two groups: With SLVI and without SLVI. Clinicopathological features compared between the two groups were patient's gender, age, tumor size, location, morphology, lymphovascular invasion, tumor differentiation, tumor budding and lymph node metastasis. The incidence of T1 CRCs with SLVI was 0.9% (7/741). All cases with SLVI were found in the sigmoid colon or rectum. T1 CRCs with SLVI showed significantly higher rates of lymphovascular invasion than those without SLVI (P<0.01). In conclusion, lymphovascular invasion was a significant risk factor for SLVI in T1 CRCs, and for which surgical colectomy was necessary. The Japanese guidelines are appropriate regarding SLVI. Registered in the University Hospital Medical Network Clinical Trials Registry (UMIN000027097).
- Open Access
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB154
575 Narrow-Band Imaging Efficiency for Evaluation of Mucosal Healing/ Relapse of Ulcerative colitis
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB154
Open Access575 Narrow-Band Imaging Efficiency for Evaluation of Mucosal Healing/ Relapse of Ulcerative colitis